Filing Flows › Profound Medical (PROF) › Guidance history
Profound Medical (PROF) guidance history: what it guided and what it reported
Profound Medical gave guidance in 4 earnings releases on file since May 7, 2026. Its releases raised guidance once and lowered it 0 times.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $25.0M (May 7, 2026) → lowered $9.8M–$10.0M (Oct 7, 2026) → raised $25.0M (Nov 5, 2026) | — | to be reported | — |
Gross margin
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 70.0% (May 7, 2026) → reaffirmed 70.0% (Aug 6, 2026) → reaffirmed 70.0% (Nov 5, 2026) | — | to be reported | — |
The latest quarter
Profound Medical, Q3 2026: revenue $9.8M (+86% year over year), operating margin -79.6%, net loss $7.7M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.
Questions
Does Profound Medical beat its guidance?
Profound Medical gave guidance in 4 earnings releases on file since May 7, 2026. Its releases raised guidance once and lowered it 0 times.
How often does Profound Medical raise guidance?
Its earnings releases raised guidance once and lowered it 0 times since May 7, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.